Future Rare Diseases is a peer-reviewed english-language open-access journal published by Taylor & Francis Group in United Kingdom, operating under an open-access model since 2021. The journal covers Internal medicine: Infectious and parasitic diseases.
Authors are required to pay an article processing charge to publish in Future Rare Diseases; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC license (see other journals using this license).
To date, Future Rare Diseases has published 138 articles. Articles are minted with DOIs through the prefix 10.2217. All submissions undergo plagiarism screening before peer review.
Keywords
rare diseases, clinical disease management, diagnosis, genetic disorders, patient advocacy, orphan drugs
At a glance
- Publisher
- Taylor & Francis Group
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Double anonymous peer review
- OA since
- 2021
- Review time
- 30 weeks
- DOI prefix
10.2217- Plagiarism check
- Yes
ISSN
- electronic
- 2399-5270
Frequently asked questions
Is Future Rare Diseases peer-reviewed?
Does Future Rare Diseases charge an article processing charge (APC)?
What subjects does Future Rare Diseases publish?
What languages does Future Rare Diseases accept?
What is the ISSN of Future Rare Diseases?
2399-5270 (electronic).